“Slezavit as a Component of Neuroprotective Therapy for Primary Open-Angle Glaucoma”, Eura. Med.Res. Per, vol. 9, pp. 93–95, Jun. 2022, Accessed: Apr. 25, 2026. [Online]. Available: https://geniusjournals.org/index.php/emrp/article/view/1726